Aspyrian Therapeutics' Corporate Minority Round

Aspyrian Therapeutics raised a round of funding on November 27, 2017. Investors include Rakuten.

Aspyrian Therapeutics focuses on developing novel targeted therapies for cancer treatments. Aspyrian Therapeutics and its collaborators are developing novel cancer targeted therapies based on propriet…

Articles about Aspyrian Therapeutics' Corporate Minority Round: